Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy

Clinical trial NCT03027245 · COMPLETED

Trial details

NCT number: NCT03027245
Sponsor: Eisai GmbH
Status: COMPLETED
Study type: OBSERVATIONAL

Locally Advanced or Metastatic Breast Cancer

Start date: 2016-10-13
Primary completion: 2022-05-31
Enrollment: 353

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.